Back to Search
DENIS LAFRENIERE, MD
MD
Otolaryngology Physician
NPI: 1699771691IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
032452(CT)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Class of 1987
Research & Publications (18)
A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.
PMID 18316361·Diabetes·2008
7-preclinical
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
PMID 16382125·J Clin Oncol·2006
3-trial
Polyglycolic acid/poly-L-lactic acid copolymer use in laryngotracheal reconstruction: a rabbit model.
PMID 15805863·Laryngoscope·2005
4-observational
Malignant mimickers: chronic bacterial and fungal infections of the larynx.
PMID 15766861·J Voice·2005
5-case
Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
PMID 15210467·Arch Dermatol·2004
4-observational
A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.
PMID 15039453·J Pharmacol Exp Ther·2004
4-observational
Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration.
PMID 12676885·J Pharmacol Exp Ther·2003
7-preclinical
Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions.
PMID 12180539·Pharm Res·2002
4-observational
Bradykinin modulation of tumor vasculature: II. activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors.
PMID 11160652·J Pharmacol Exp Ther·2001
7-preclinical
Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy.
PMID 11160651·J Pharmacol Exp Ther·2001
7-preclinical
Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain.
PMID 11145226·Pharm Res·2000
7-preclinical
Soft tissue response in the rabbit larynx following implantation of LactoSorb (PLA/PGA copolymer) prosthesis for medialization laryngoplasty.
PMID 11021506·J Voice·2000
7-preclinical
Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
PMID 10990194·Pharm Res·2000
7-preclinical
Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
PMID 10990193·Pharm Res·2000
7-preclinical
Growth-related oncogene-alpha expression in human nasal polyps.
PMID 10889487·Otolaryngol Head Neck Surg·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UCONN MEDICAL GROUP, 263 FARMINGTON AVENUE
FARMINGTON, CT 06030 - Phone
- (860) 679-2804
Quick Facts
- NPI
- 1699771691
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 18
Are you this provider?
Claim Your Profile